The developed model can effectively explain heterogeneity in future glycaemic response of patients with type 2 diabetes. It can therefore be used in clinical practice as a quick and easy tool to provide tailored diabetes care.
No takes yet. Share an insight, caveat, or question.
Hertroijs et al. (2017) studied this question.